Major reduction in tumor mass (7 mm residual tumor) and NPM1 negativity were achieved after one block of FLAG (fludarabine, cytarabine, filgrastim) and two blocks of FLAG-mitoxantrone. Here, NPM1 is linked to neoplasm.